Enclomiphene vs TRT: A Fertility-Friendly Alternative to Testosterone

If you want higher testosterone but you still want kids, standard TRT puts you in a bind. Injecting or rubbing on testosterone fixes your numbers fast. It can also shut down your own sperm production. Enclomiphene and its older cousin clomiphene work a different way. They nudge your body to make more of its own testosterone, and they usually keep your fertility intact.

This guide breaks down the real trade-offs, what the studies actually show, and how to decide which path fits your goals.

Medical disclaimer: This article is for education only. It is not medical advice. Enclomiphene and clomiphene are not FDA-approved to treat male hypogonadism, and using them this way is off-label. Testosterone, fertility, and hormone treatment decisions should be made with a licensed physician who can review your labs and history. Never start, stop, or change any medication on your own.

Quick Answer

• Enclomiphene and clomiphene raise your own testosterone instead of replacing it. They block estrogen feedback in the brain, so your body makes more LH and FSH and pumps out more natural testosterone. Standard TRT does the opposite and tells your testicles to stand down.
• Fertility is the deciding factor. TRT can shrink your testicles and crash your sperm count. In a randomized trial, enclomiphene kept sperm counts up while a testosterone gel pushed them down (Wiehle 2014, PMID 25044085). If you want to father children soon, this matters a lot.
• Both raise testosterone, but not always to the same range. Clomiphene and enclomiphene reliably lift total testosterone into the normal range for most men with secondary (low-LH) hypogonadism. They tend to land in the mid-to-high-normal zone rather than the very high numbers some men chase on injections.
• Neither is FDA-approved for low T. Enclomiphene is investigational and only available compounded. Clomiphene is FDA-approved for female infertility and used off-label in men. TRT products are FDA-approved but carry their own warnings. All three need a doctor.

What Is the Difference Between Enclomiphene, Clomiphene, and TRT?

Start with how each one acts on your body. This is the core of the whole decision.

Your testosterone is run by a feedback loop called the HPG axis (hypothalamic-pituitary-gonadal axis). Your brain releases GnRH, your pituitary releases LH and FSH, and those hormones tell your testicles to make testosterone and sperm. When testosterone or estrogen rises, the brain senses it and dials production back down. That is the brake.

TRT (testosterone replacement therapy) adds testosterone from the outside. Your blood level goes up. But your brain sees that high level and slams the brake. LH and FSH drop close to zero. With no signal coming in, your testicles slow down and often stop making sperm. They can shrink. This is why TRT is a known cause of male infertility (Endocrine Society Guideline, Bhasin 2018, PMID 29562364).

Clomiphene citrate is a selective estrogen receptor modulator, or SERM. It blocks estrogen receptors in the hypothalamus. Your brain can no longer "see" the estrogen, so it thinks testosterone is low and pushes harder. GnRH, LH, and FSH all go up. Your own testicles make more testosterone, and because FSH stays up, sperm production keeps running (Clomiphene mechanisms review, 2024, PMC11435126).

Enclomiphene is one of the two molecules inside clomiphene. Clomiphene is a 50/50 mix of two isomers: enclomiphene and zuclomiphene. Enclomiphene is the part that does the testosterone-raising work and clears out of the body fast. Zuclomiphene is more estrogen-like, hangs around for weeks, and is blamed for some of clomiphene's side effects like mood changes and visual symptoms. Enclomiphene is the "cleaned up" version, designed to keep the benefit and drop the baggage.

The takeaway: TRT works despite your HPG axis. Enclomiphene and clomiphene work through it. That single difference drives nearly every pro and con below.

Does Enclomiphene Actually Protect Fertility Better Than TRT?

Short answer: yes, and there is randomized trial data behind it.

The most cited study is a phase II randomized trial by Wiehle and colleagues. Men with low testosterone got either enclomiphene, a topical testosterone gel, or placebo. After treatment, the men on enclomiphene kept their sperm counts. The men on the testosterone gel saw sperm counts fall. Enclomiphene also raised LH and FSH, while the gel suppressed them (Wiehle 2014, PMID 25044085). That is the fertility story in one trial.

An earlier comparison study by Kaminetsky found the same pattern. Oral enclomiphene raised endogenous testosterone and kept sperm counts steady, while testosterone gel suppressed the hormones that drive sperm production (Kaminetsky 2013, PMID 23530575).

Why does this happen? It comes back to FSH. Sperm production depends on FSH and on high testosterone inside the testicle (intratesticular testosterone, far higher than blood levels). TRT floods the blood but cuts FSH and intratesticular testosterone, so the sperm factory shuts down. Enclomiphene raises FSH and keeps the factory running.

One honest caveat: TRT-induced infertility is usually reversible. After stopping TRT, most men recover sperm production, though it can take many months and sometimes longer than a year. For some men, especially older ones or those on TRT for years, recovery is slower or incomplete. If you want kids in the near term, "probably reversible eventually" is a weak plan. That is the case for enclomiphene.

If you're already on TRT and want to protect fertility, there are add-on options like hCG. We cover those in our guide on TRT and fertility with hCG and enclomiphene.

How Well Does Enclomiphene Raise Testosterone Compared to TRT?

Both raise testosterone. The question is how much, and into what range.

For men with secondary hypogonadism (low testosterone caused by a weak brain signal, not failed testicles), enclomiphene and clomiphene work well. The HPG axis is intact; it just needs a push. In the trials, enclomiphene moved men's testosterone into the normal range, roughly comparable to a testosterone gel (Wiehle 2014, PMID 25044085).

A 2022 systematic review and meta-analysis of clomiphene in hypogonadal men found it consistently raised total testosterone, LH, and FSH versus baseline and versus placebo, with a good safety profile (Huijben 2022, PMID 34933414). A long-term study followed men on clomiphene for up to several years and found sustained testosterone improvement with few side effects (Krzastek 2019, PMID 31216250).

Here's the key limit. SERMs need a working pituitary and working testicles to respond. If you have primary hypogonadism (the testicles themselves have failed, with already-high LH and FSH), there is no brake to release. Pushing the brain harder does nothing because the testicles can't answer. Those men generally need TRT.

Also worth saying plainly: TRT can push testosterone wherever the dose takes it, including supraphysiologic levels. SERMs generally land you in the mid-to-high-normal range and no higher, because the body's own feedback still caps the output. If you want hormone numbers in the normal range while keeping fertility, that cap is a feature. If you're chasing very high levels for body composition, SERMs will disappoint you.

To learn how doctors decide whether you even have a deficiency, see our guide on low-testosterone symptoms and diagnosis.

What Are the Side Effects and Risks of Each Option?

Every option has trade-offs. None is "free."

Enclomiphene and clomiphene side effects are usually mild. The most common are mood changes, headache, nausea, and in a smaller number of men, visual symptoms like blurriness or floaters. Visual side effects are more linked to the long-lasting zuclomiphene isomer in clomiphene, which is part of why the purer enclomiphene was developed. These usually go away when the drug is stopped. SERMs can raise estrogen along with testosterone, since more testosterone means more raw material for estrogen (Wheeler 2019, PMID 30522888).

TRT side effects are better documented because the drugs are FDA-approved and widely used. The big ones are a rise in red blood cell count (polycythemia), which can thicken the blood; testicular shrinkage; acne; and suppressed fertility. The FDA requires class-wide warnings on testosterone products, including a warning about increased blood pressure (FDA class-wide labeling changes, 2025). The Endocrine Society recommends monitoring hematocrit and PSA on TRT (Bhasin 2018, PMID 29562364).

One advantage of the SERM route: it tends to need lighter monitoring than TRT, mainly because it doesn't drive the red-blood-cell increase that injections often do. You still need labs. But fewer men land in the "your hematocrit is too high, we have to pause" conversation. For what regular monitoring looks like, see our TRT blood work and lab schedule guide.

Is Enclomiphene FDA-Approved, and Can You Even Get It?

This is where a lot of guides get fuzzy. Here is the straight version.

Enclomiphene is not FDA-approved for any use. A branded version (Androxal) went through trials and received a Complete Response Letter from the FDA in 2015 over study-design questions. The original developer later shelved it. So when men get enclomiphene today, it comes from a compounding pharmacy with a prescription. Compounded drugs are not FDA-reviewed for safety, quality, or effectiveness ahead of time, which is a real trade-off to understand.

Clomiphene citrate is FDA-approved, but only for inducing ovulation in women. Using it for male hypogonadism is off-label. That's legal and common, but it means the male use isn't on the official label.

TRT products are FDA-approved for men with diagnosed hypogonadism. That gives them the most regulatory backing, the most safety data, and clear labeling, including the required warnings.

Where do guidelines land? The AUA (American Urological Association) Guideline notes that clomiphene is a reasonable option to keep fertility in men who want it, and that men should be told TRT can suppress sperm production (AUA Guideline, Mulhall 2018, PMID 29601923). The Endocrine Society guideline focuses on TRT but is clear that exogenous testosterone suppresses spermatogenesis (Bhasin 2018, PMID 29562364).

A practical note: because enclomiphene is compounded, pricing and quality vary by pharmacy. Always use a provider who sources from a reputable compounder. To compare what each route costs over a year, run the numbers in our TRT cost calculator.

How Do You Decide Between Enclomiphene, Clomiphene, and TRT?

Walk through it like a doctor would. Three questions sort most men.

1. Do you have primary or secondary hypogonadism? Your doctor checks LH and FSH on your labs. If they are low or normal with low testosterone, that's secondary, and SERMs can work. If LH and FSH are already high, that's primary, and SERMs won't help. You need TRT.

2. Do you want children, now or later? If yes, lean hard toward enclomiphene or clomiphene. They keep the sperm factory open. If your family is complete, TRT becomes a reasonable option, and you may prefer its higher ceiling and stronger track record.

3. What's your goal for the numbers? If you want to feel better with testosterone in the normal range, SERMs often get you there with lighter monitoring. If you want maximum levels for performance or body composition, only TRT delivers that, with the side-effect and fertility cost that comes with it.

There's a middle path some men take: start on enclomiphene or clomiphene to preserve fertility, finish their family, then switch to TRT if needed. Others stay on a SERM long-term because it works and feels cleaner. Both are legitimate, and both should be doctor-guided.

For a side-by-side comparison of how testosterone gets delivered once you do choose TRT, see our TRT delivery methods guide, and our overview of TRT side effects and safety.

How to Talk to a Provider About This

You don't need to walk in with a prescription request. You need the right labs and the right questions.

Ask for a full hormone panel: total and free testosterone, LH, FSH, estradiol, and a basic metabolic check. The LH and FSH numbers decide whether a SERM can even work for you. Bring up fertility early and clearly, even if you're "pretty sure" you're done having kids, because that one fact changes the whole plan.

Good questions to ask:

• Is my low testosterone primary or secondary, based on my LH and FSH?
• Given my fertility goals, is a SERM a better first step than TRT?
• If I start TRT, what's my realistic plan to protect or recover fertility?
• How often will you check my labs, and which ones?
• What does each option cost out of pocket, since enclomiphene usually isn't covered?

Not every clinic offers enclomiphene, since it has to be compounded. If yours doesn't, ask about clomiphene, which any pharmacy can fill. To find clinics that handle fertility-sparing options, browse our TRT provider directory, and weigh telehealth versus in-person care in our how to choose a TRT provider guide.

Frequently Asked Questions

Will enclomiphene make me infertile like TRT can? No, and that's its main selling point. In randomized trials, enclomiphene kept sperm counts up while a testosterone gel pushed them down (Wiehle 2014, PMID 25044085). It raises FSH, the hormone that drives sperm production, instead of suppressing it like TRT does.

Is enclomiphene better than clomiphene? They work the same way. Enclomiphene is the single "active" isomer pulled out of clomiphene, designed to keep the testosterone benefit while dropping the side effects tied to clomiphene's longer-lasting zuclomiphene part, like mood and visual symptoms (Wheeler 2019, PMID 30522888). In practice, both raise testosterone well in men with secondary hypogonadism. Clomiphene is cheaper and easier to get; enclomiphene may be gentler on side effects but is compounded only.

Can I take enclomiphene long-term, or just to have kids? Both are done. Some men use a SERM only while trying to conceive, then switch. Others stay on it for years. A long-term study found clomiphene kept testosterone up with few side effects over an extended period (Krzastek 2019, PMID 31216250). Long-term use should be monitored by a doctor.

Does enclomiphene raise testosterone as high as injections? Usually not. SERMs move most men with secondary hypogonadism into the normal range, often mid-to-high-normal, but the body's own feedback caps the output (Huijben 2022, PMID 34933414). Injections can push levels higher, including above normal. For feeling well while keeping fertility, the normal-range cap is usually a plus.

Is enclomiphene covered by insurance? Usually not, because it's compounded and not FDA-approved. Clomiphene is sometimes covered. TRT is often covered with a documented hypogonadism diagnosis. Costs vary widely, so compare them in our TRT cost calculator before you commit.

Related Guides

• TRT and Fertility: HCG and Enclomiphene Explained
• Do I Need TRT? Low-Testosterone Symptoms & How It's Diagnosed
• TRT Delivery Methods: Injections vs Cream vs Pellets
• TRT Side Effects & Safety: What the Evidence Says
• TRT Blood Work: The Labs & Monitoring Schedule
• Compare TRT options and providers
• Estimate your cost with the TRT cost calculator

Sources

1. Wiehle RD, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial. Fertility and Sterility, 2014. PMID 25044085
2. Kaminetsky J, et al. Oral enclomiphene citrate stimulates endogenous testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. The Journal of Sexual Medicine, 2013. PMID 23530575
3. Huijben M, et al. Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. Andrology, 2022. PMID 34933414
4. Krzastek SC, et al. Long-Term Safety and Efficacy of Clomiphene Citrate for the Treatment of Hypogonadism. The Journal of Urology, 2019. PMID 31216250
5. Wheeler KM, Sharma D, Kavoussi PK, Smith RP, Costabile R. Clomiphene Citrate for the Treatment of Hypogonadism. Sexual Medicine Reviews, 2019. PMID 30522888
6. Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of Urology, 2018. PMID 29601923
7. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018. PMID 29562364
8. Clomiphene Citrate Treatment as an Alternative Therapeutic Approach for Male Hypogonadism: Mechanisms and Clinical Implications. 2024. PMC11435126
9. U.S. Food and Drug Administration. FDA issues class-wide labeling changes for testosterone products. 2025. FDA.gov